- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imaging veteran Mason joins eMed as CEO
Imaging veteran Mason joins eMed as CEOPACS and imaging veteran Caren Mason has joined eMed Technologies as CEO in a move intended to strengthen the company’s resources as it broadens into Web-based image workflow products and services.
Imaging veteran Mason joins eMed as CEO
PACS and imaging veteran Caren Mason has joined eMed Technologies as CEO in a move intended to strengthen the companys resources as it broadens into Web-based image workflow products and services. Former CEO and president Scott Sheldon continues as president of the Lexington, MA-based firm and will work closely with Mason to further eMeds growth and expansion.
Mason brings to eMed more than 20 years experience in healthcare imaging and information businesses, most recently as general manager of the Womens Healthcare business for General Electric. Prior to GE she was senior vice president of the technical imaging business group for Agfa, where she headed up the Agfa Medical, Motion Picture, Nondestructive Testing, and Micrographics businesses. She has also held management positions at Baxter Healthcare.
© 2000 Miller Freeman, Inc., a United News & Media company
- Search again
- Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
